Incidence, Prevalence and Current Treatment Practice of Systemic Lupus Erythematosus: A German Claims Data Analysis. In: J. S. Smolen (Hrsg.). admin8. November 2025
Incidence, Prevalence and Management of Systemic Lupus Erythematosus in 4 Cohorts: a German Claims Data Analysis. EV.14. In: Deutsche Gesellschaft für Rheumatologie e. V. (Hrsg.). admin8. November 2025
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study. admin8. November 2025
Health Care Costs of Patients With Systemic Lupus Erythematosus (SLE) Versus Control Patients as a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund. admin8. November 2025
Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. admin8. November 2025
Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. admin8. November 2025
Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany admin8. November 2025
Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. admin8. November 2025
Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. admin8. November 2025
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany. admin8. November 2025
